Cells (Mar 2022)

Development of a Chemical Cocktail That Rescues Mouse Brain Demyelination in a Cuprizone-Induced Model

  • Pei-Lun Lai,
  • Chi-Hou Ng,
  • Chia-Hsin Wu,
  • Chien-Ying Lai,
  • Scott C. Schuyler,
  • Vicki Wang,
  • Hsuan Lin,
  • Yueh-Chang Lee,
  • Ming-Hsi Chuang,
  • Chang-Huan Yang,
  • Wei-Ju Chen,
  • Hsiao-Chun Huang,
  • Jean Lu

DOI
https://doi.org/10.3390/cells11071091
Journal volume & issue
Vol. 11, no. 7
p. 1091

Abstract

Read online

Oligodendrocytes are glial cells located in the central nervous system (CNS) that play essential roles in the transmission of nerve signals and in the neuroprotection of myelinated neurons. The dysfunction or loss of oligodendrocytes leads to demyelinating diseases such as multiple sclerosis (MS). To treat demyelinating diseases, the development of a therapy that promotes remyelination is required. In the present study, we established an in vitro method to convert human fibroblasts into induced oligodendrocyte-like cells (iOLCs) in 3 days. The induced cells displayed morphologies and molecular signatures similar to oligodendrocytes after treatment with valproic acid and exposure to the small molecules Y27632, SU9516, and forskolin (FSK). To pursue the development of a cell-free remyelination therapy in vivo, we used a cuprizone-induced demyelinated mouse model. The small molecules (Y27632, SU9516, and FSK) were directly injected into the demyelinated corpus callosum of the mouse brain. This combination of small molecules rescued the demyelination phenotype within two weeks as observed by light and electron microscopy. These results provide a foundation for exploring the development of a treatment for demyelinating diseases via regenerative medicine.

Keywords